How Parkinson’s Affects the Way We Walk — And What Dopamine Treatment Does About It

Parkinson’s disease is well known for its impact on movement—especially walking. But not everyone with Parkinson’s walks the same way. Some people are more rigid, others are shakier, and some may struggle with freezing (suddenly stopping). This study looked closely at how different walking styles (called motor phenotypes) affect gait—and how dopamine medication helps (or doesn’t). What did the researchers do? They studied 71 people with Parkinson’s and grouped them by their main motor type: Tremor-dominant (TD) Postural Instability/Gait Difficulty (PIGD) Intermediate types They then used special technology to measure how these people walked—both with and without dopaminergic medication (like levodopa). They looked at: Spatiotemporal parameters: how long each step takes, how big the steps are, etc. Kinematic parameters: how joints (like the knees and hips) move during walking. What did they find? 🦶 Everyone with Parkinson’s had altered gait compared to healthy individuals—but the type of Parkinson’s mattered. 📉 The PIGD group had the most serious walking problems: Shorter steps Slower pace Trouble lifting their feet Limited movement in joints 💊 Dopamine medications helped improve walking in most people—especially: Increased step length and walking speed Better joint movement But—PIGD patients didn’t respond as well. Even after medication, their walking remained more impaired compared to the TD and intermediate groups. Why does this matter? This study shows that Parkinson’s isn’t one-size-fits-all. The way the disease affects walking depends on your motor type, and so does your response to medication. 💡 For people with more severe walking issues (PIGD type), we may need to combine dopamine therapy with: Physiotherapy Balance training Assistive devices Or even consider advanced options like DBS